PM&R
Volume 1, Issue 9 , Pages 852-858 , September 2009

Intrathecal Baclofen Therapy: An Update

  • Gerard E. Francisco, MD

      Affiliations

    • University of Health Science Center-Houston, the Institute for Rehabilitation and Research, Houston, TX†
    • ,
  • Michael F. Saulino, MD, PhD

      Affiliations

    • MossRehab, Albert Einstein Healthcare Network, Jefferson Medical College, Philadelphia, PA‡
    • Corresponding Author InformationAddress correspondence to M.S.
    • ,
  • Stuart A. Yablon, MD

      Affiliations

    • Methodist Rehabilitation Center, University of Mississippi Medical Center, Jackson, MS§
    • ,
  • Michael Turner, MD

      Affiliations

    • Indianapolis Neurosurgical Group, Indianapolis, IN

Received 14 July 2009 ,Accepted 30 July 2009.

References 

  1. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA. 1993;270:2475–2477
  2. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg. 2003;98:291–295
  3. Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil. 2001;82:155–161
  4. Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320:1517–1521
  5. Coffey JR, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study. J Neurosurg. 1993;78:226–232
  6. Ordia JI, Fischer E, Adamski E, Spatz EL. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg. 1996;85:452–457
  7. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity (A prospective study). Am J Phys Med Rehabil. 1992;71:321–327
  8. Meythaler JM, McCary A, Hadley MN. Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: A preliminary report. J Neurosurg. 1997;87:415–419
  9. Becker R, Alberti O, Bauer BL. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol. 1997;244:160–166
  10. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004;10:589–595
  11. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN. Intrathecal baclofen for spastic hypertonia from stroke. Stroke. 2001;32:2099–2109
  12. Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T, Grissom SP. Intrathecal baclofen management of poststroke spastic hypertonia: Implications for function and quality of life. Arch Phys Med Rehabil. 2006;87:1509–1515
  13. Francisco GE, Boake C. Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: A preliminary study. Arch Phys Med Rehabil. 2003;84:1194–1199
  14. Sadiq SA, Wang GC. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. J Neurol. 2006;253:563–569
  15. Schiess MC, Acosta F, Izor R, Fischer S, Furr E, Simpson R. Functional motor control improvement after intrathecal baclofen pump therapy in stroke related hemiplegia. Neural Repair. 2006;66:
  16. Hoving MA, van Raak EP, Spincemaille GH, et al. Intrathecal baclofen in children with spastic cerebral palsy: A double-blind, randomized, placebo-controlled, dose-finding study. Dev Med Child Neurol. 2007;49:654–659
  17. Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity: A clinical survey. Am J Phys Med Rehabil. 2000;79:536–541
  18. Horn TS, Yablon SA, Stokic DS. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil. 2005;86:1127–1133
  19. Stokic DS, Yablon SA, Hayes A. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury. Arch Phys Med Rehabil. 2005;86:1801–1806
  20. Baguley IJ, Bailey KM, Slewa-Younan S. Prolonged anti-spasticity effects of bolus intrathecal baclofen. Brain Inj. 2005;19:545–548
  21. Azouvi P, Roby-Brami A, Biraben A, Thiebaut JB, Thurel C, Bussel B. Effect of intrathecal baclofen on the monosynaptic reflex in humans: Evidence for a postsynaptic action. J Neurol Neurosurg Psychiatry. 1993;56:515–519
  22. Bleyenheuft C, Filipetti P, Caldas C, Lejeune T. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy. Neurophysiol Clin. 2007;37:23–28
  23. Burns AS, Meythaler JM. Intrathecal baclofen in tetraplegia of spinal origin: Efficacy for upper extremity hypertonia. Spinal Cord. 2001;39:413–419
  24. Staats PS. Complications of intrathecal therapy. Pain Med. 2008;9:S102–S107
  25. Deer T, Chapple I, Classen A, et al. Intrathecal drug delivery for treatment of chronic low back pain: Report from the national outcomes registry for low back pain. Pain Med. 2004;5:6–13
  26. Rathmell JP, Lake T, Ramundo MB. Infectious risks of chronic pain treatments: Injection therapy, surgical implants, and intradiscal techniques. Reg Anesth Pain Med. 2006;31:346–352
  27. Burgher AH, Barnett CF, Obray JB, Mauck WD. Introduction of infection control measures to reduce infection associated with implantable pain therapy devices. Pain Pract. 2007;7:279–284
  28. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Reg Anesth Pain Med. 2003;28:172–197
  29. Albright AL, Turner M, Pattisapu JV. Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg. 2006;104(4 Suppl):233–239
  30. Coffey RJ, Edgar TS, Francisco GE, et al. Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil. 2002;83:735–741
  31. Stinchon JF, Shah NP, Ordia J, Oates E. Scintigraphic evaluation of intrathecal infusion systems: Selection of patients for surgical or medical management. Clin Nucl Med. 2006;31:1–4
  32. Lew SM, Psaty EL, Abbott R. An unusual cause of overdose after baclofen pump implantation: Case report. Neurosurgery. 2005;56:E624;discussion E624
  33. Dawes WJ, Drake JM, Fehlings D. Microfracture of a baclofen pump catheter with intermittent under- and overdose. Pediatr Neurosurg. 2003;39:144–148
  34. Ansari NN, Naghdi S, Arab TK, Jalaie S. The interrater and intrarater reliability of the modified Ashworth scale in the assessment of muscle spasticity: Limb and muscle group effect. NeuroRehabilitation. 2008;23:231–237
  35. Platz T, Eickhof C, Nuyens G, Vuadens P. Clinical scales for the assessment of spasticity, associated phenomena, and function: A systematic review of the literature. Disabil Rehabil. 2005;27:7–18
  36. Stokic DS, Yablon SA. Neurophysiological basis and clinical applications of the H-reflex as an adjunct for evaluating response to intrathecal baclofen for spasticity. Acta Neurochir Suppl. 2007;97:231–241
  37. Knikou M. The H-reflex as a probe: Pathways and pitfalls. J Neurosci Methods. 2008;171:1–12
  38. Abbruzzese G. The medical management of spasticity. Eur J Neuro. 2002;9(Suppl 1):30–34discussion 53-61
  39. Orsnes G, Crone C, Krarup C, Petersen N, Nielsen J. The effect of baclofen on the transmission in spinal pathways in spastic multiple sclerosis patients. Clin Neurophysiol. 2000;111:1372–1379
  40. Hill DR, Bowery NG. 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain. Nature. 1981;290:149–152
  41. Yang K, Wang D, Li YQ. Distribution and depression of the GABA(B) receptor in the spinal dorsal horn of adult rat. Brain Res Bull. 2001;55:479–485
  42. Crone C, Johnsen LL, Hultborn H, Orsnes GB. Amplitude of the maximum motor response (mmax) in human muscles typically decreases during the course of an experiment. Exp Brain Res. 1999;124:265–270
  43. Sorokin A, Annabi E, Yang WC, Kaplan R. Subdural intrathecal catheter placement: Experience with two cases. Pain Physician. 2008;11:677–680
  44. Pasquier Y, Cahana A, Schnider A. Subdural catheter migration may lead to baclofen pump dysfunction. Spinal Cord. 2003;41:700–702
  45. Yablon SA, Stokic DS. Neurophysiologic evaluation of spastic hypertonia: Implications for management of the patient with the intrathecal baclofen pump. Am J Phys Med Rehabil. 2004;83(10 Suppl):S10–S18

 Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org

PII: S1934-1482(09)00760-6

doi: 10.1016/j.pmrj.2009.07.015

PM&R
Volume 1, Issue 9 , Pages 852-858 , September 2009

Article Tools

* Image Usage & Resolution